Bay Area big winner in bird flu funding

05/5/2006 | Bradenton Herald (Fla.)

Novartis and MedImmune will receive $400 million over the next five years as part of the U.S. government's $1 billion pledge to develop a bird flu vaccine. Swiss-based Novartis will do its work out of its California Chiron facility, while Maryland-based MedImmune will also do its work at a California facility.

View Full Article in:

Bradenton Herald (Fla.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT